Resources from the same session
387MO - Tumour mutation profiles and circulating tumour cells in metastatic colorectal cancer patients treated with FOLFIRI + cetuximab: A prospective ancillary study of the UNICANCER PRODIGE-28 trial
Presenter: Hélène Blons
Session: Mini oral session - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
388MO - Tumor budding, an important prognostic factor in stage III colon cancer patients treated with oxaliplatin-based chemotherapy
Presenter: Debora Basile
Session: Mini oral session - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
389MO - Risk of bowel obstruction in patients undergoing neoadjuvant chemotherapy for high-risk colon cancer: A nested case-control matched analysis of an international, multi-centre, randomised controlled trial (FOxTROT)
Presenter: James Glasbey
Session: Mini oral session - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
390MO - Colorectal (CRC) cancer screening and diagnosis during the COVID-19 pandemic in Quebec, Canada
Presenter: Mustapha Tehfe
Session: Mini oral session - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
391MO - Impact of diabetes and metformin use on recurrence and outcome in early colon cancer (CC) patients: A pooled analysis of 3 adjuvant trials
Presenter: Elisabeth Bergen
Session: Mini oral session - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
Discussion 387MO, 388MO and 389MO
Presenter: Clara Montagut Viladot
Session: Mini oral session - Gastrointestinal tumours, colorectal
Resources:
Slides
Webcast